Filter By Category
Archives
Share on -
ACOLBIFENE
Generic Name: ACOLBIFENE
ABSTRACT -
Acolbifene is a selective estrogen receptor modulator (SERM) that has been investigated for hormone-dependent cancers, particularly breast cancer and endometrial cancer. It acts as a pure estrogen antagonist in breast and uterine tissue without agonist activity, distinguishing it from earlier generation SERMs. It has also been studied for contraceptive applications.
DOSAGE -
Acolbifene is an investigational drug. Dosage used in clinical trials has typically ranged from 20 mg to 60 mg orally per day. No approved dosage for routine clinical use. Administered only within clinical trial settings.
SIDE EFFECTS –
Reported or potential side effects may include:
- Hot flashes
- Vaginal dryness
- Headache
- Nausea
- Fatigue
- Musculoskeletal discomfort
- Mood changes
ALLRGIC REACTIONS–
(These symptoms may indicate an allergic reaction to the drug.)
- Skin rash
- Itching
- Angioedema
- Urticaria
- Severe hypersensitivity
DRUG INTERACTIONS–
- CYP3A4 inducers and inhibitors
- Estrogen-containing medications
- Anticoagulants
- Other hormonal therapies
PREAUTIONS–
- Not recommended during pregnancy.
- Bone density monitoring may be required.
- Caution in patients with thromboembolic history.
- Inform physician of all current medications.
- Follow clinical trial monitoring requirements.
WARNINGS –
- Not approved for general medical use.
- Risk of thromboembolic events.
- Long-term endometrial safety requires evaluation.
- Keep out of reach of children.
- Report any abnormal bleeding or adverse reactions promptly.
Share on -
. Developed by